Delivery Order SPE2DB24D1021-SPE2DB25FFAMU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,159.11 to AmerisourceBergen Drug Corp for the supply of Aspirin-Dipyridamole Extended Release 25-200 mg tablets (60 count) on August 13, 2025, with completion scheduled for August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,645.27 firm fixed-price contract is for the delivery of ASPIRIN-DIPYRIDAM ER 25-200 MG UU 60S medication. The contract has a period of performance through May 7, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This delivery order for $266 was awarded to Amerisourcebergen Drug Corporation by the Defense Logistics Agency on October 10, 2023. The order is for 60 units of Asprin-Dipyridamole extended release tablets between 25-200 milligrams, to be delivered by October 11, 2023. The pricing is firm fixed price. Place of performance will be Amerisourcebergen's corporate office located in Conshohocken, Pennsylvania. No set-aside designation was used for this order under the DLA's pharmaceuticals supply...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,400 to Amerisourcebergen Drug Corporation. The order is for 100 count bottles of 325mg aspirin tablets to be delivered to a facility in Conshohocken, Pennsylvania by September 11, 2023. Amerisourcebergen Drug Corporation will perform as the prime contractor, with its parent company listed as Amerisourcebergen Corporation. The delivery order was awarded under an existing DLA contract vehicle to fulfill...
- This delivery order, awarded by the Defense Logistics Agency on October 4, 2023, is for the supply of 325 mg aspirin tablets to Amerisourcebergen Drug Corp. The order is for 100 tablets with a firm fixed price of three dollars. Performance will take place in Conshohocken, Pennsylvania, with an expected completion date of October 5, 2023. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support of the U.S. military,...
- The Defense Logistics Agency awarded a $2,050 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 81 mg aspirin chewable tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 36 count bottles of the chewable aspirin tablets to a facility in Conshohocken, Pennsylvania by July 27, 2023 to fulfill requirements under the contract. The parent company, Amerisourcebergen Corporation, will perform the work through its Amerisourcebergen Corporation...
- The Defense Logistics Agency awarded a $13,920.91 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This contract utilizes firm fixed price terms with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award was issued on July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a...
- The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for Orserdu 345 mg tablets (30-count units) on August 29, 2025, with an ultimate completion date of September 22, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- Amerisourcebergen Drug Corp was awarded a delivery order against an unspecified government-wide acquisition contract on October 16, 2023 by the Defense Logistics Agency. The firm fixed price order, valued at one dollar, is for the delivery of 36 chewable 81 mg aspirin tablets to a location in Conshohocken, Pennsylvania. Performance is required no later than October 17, 2023. No set-aside provision was applied to this procurement for the pharmaceutical products. Amerisourcebergen Drug Corp will...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAMUDelivery Order
The Defense Logistics Agency awarded a $2,619.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Aspirin-Dipyridamole ER 25-200 mg tablets in quantities of 60 units. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, involves no set-aside designation and will be completed by September 11, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply relationship with the Defense Logistics Agency, which maintains a $999.999 billion prime indefinite delivery vehicle through December 2026 to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive portfolio of medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The non-set-aside competitive award reflects the contractor's capability to fulfill federal pharmaceutical supply requirements and demonstrates the company's role in supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/10/25 |